Company Filing History:
Years Active: 2000-2002
Title: The Innovations of Inventor Su Wu
Introduction
Su Wu is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of glutamate receptors. With a total of 3 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
One of Su Wu's latest patents is for the Metabotropic glutamate receptor 4 nucleic acid. This invention describes a novel human glutamate receptor, designated mGluR4. It encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds. Another significant patent is for isolating nucleic acid encoding human MGLUR8. This invention describes a novel human glutamate receptor, designated mGluR8, and also includes nucleic acids encoding this receptor, or a fragment thereof, along with methods employing this receptor and the nucleic acid compounds.
Career Highlights
Su Wu is currently employed at Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development. His work at Eli Lilly has allowed him to focus on groundbreaking research in the field of neuroscience and pharmacology.
Collaborations
Su Wu collaborates with various professionals in his field, including his coworker, Rama M Belagaje. Their combined expertise contributes to the advancement of research and development in their respective areas.
Conclusion
In summary, Su Wu is a notable inventor whose work on glutamate receptors has the potential to lead to significant advancements in medical science. His contributions at Eli Lilly and Company highlight the importance of innovation in the pharmaceutical industry.